Home|Journals|Articles by Year Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Original Research

Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated

Nicholas P Booth, Wells Brockbank, Samuel Oh, Karl Kingsley.

Warning: mysql_num_rows() expects parameter 1 to be resource, boolean given in /home2/bibliomed/depo/functions_site.php on line 126

Objective: Oral cancers are slow developing tumors that affect thousands of individuals in the US annually. Evidence has shown that these cancers can create microenvironments to enhance their progression, survival and metastasis characteristics. Cancer cells will compete for extracellular nutrients with normal tissue cells, which can cause irregularities in immune regulation of progressive cancers. Recent evidence in other types of cancers have suggested that tumor cells may actually upregulate the consumption of extracellular L-tryptophan and increase the export of cytosolic kynurenine byproduct. These kynurenines have been linked to suppression of local immune response of T-cells. The primary goal of this study was to evaluate oral cancer cell lines for tryptophan dioxygenase (TDO) and Indolamine 2,3-dioxygenase (IDO) expression and elucidate whether or not other flavonoids inhibit enzyme expression and cancer growth. Methods: Oral cancer cell lines SCC25, SCC15, and CAL27 were screened for enzyme expression using mRNA specific primers and RT-PCR. The three cell lines were then subjected to proanthocyanidin (PAC) administration to determine potential growth and enzyme inhibition. Results: This study found that IDO and TDO are expressed in the SCC25, SCC15, and CAL27 oral cancer cell lines and enzyme expression is correlated with tumor growth. Additionally, it was observed that IDO and TDO expression, along with tumor growth, can be inhibited by flavonoid administration. Conclusions: With no real treatment advances in many years and survival rates remaining relatively unchanged, these results provide further knowledge in the understanding of oral cancer mechanisms and function that may lead to future treatment modalities. Our demonstration of enzyme down regulation and growth inhibition induced by flavonoids may also contribute to further research in future novel treatments.

Key words: Indoleamine 2,3-dioxygenase (IDO); Oral squamous cell carcinoma (OSCC); Tryptophan dioxygenase (TDO)

Full-text options

Full-text Article

Readers of this article also read the following articles
»A New Marker For The Diagnosýs Of Sepsis: Presepsin
»The Importance of Serum Procalcitonin in Diagnosis and Treatment of Serious Bacterial Infections and Sepsis
»The effect of maternal anthropometric characteristics and social factors on birth weight of child in small town hospital of Gandevi block of Navsari district.
»Shifting trends of HIV epidemiology among most at risk groups (MARGs) in India
»Toxicities due to highly active anti-retroviral therapy (HAART) in HIV-positive children: need for further medical research
»Prevalence of overweight and obesity in affluent adolescent girls in Surat city, western India
»Sample size in clinical research, the number we need
»Delayed onset renal failure following multiple bee stings
»Beware – statistics may deceive you
»Why one more journal?
»A study of sacrum with three pairs of sacral foramina in western India

American Journal of Research in Medical Sciences


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.